Target Price | $328.62 |
Price | $241.55 |
Potential | 36.04% |
Number of Estimates | 41 |
41 Analysts have issued a price target Tesla 2026 . The average Tesla target price is $328.62. This is 36.04% higher than the current stock price. The highest price target is $500.00 107.00% , the lowest is $120.00 50.32% . | |
A rating was issued by 55 analysts: 29 Analysts recommend Tesla to buy, 14 to hold and 12 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Tesla stock has an average upside potential 2026 of 36.04% . Most analysts recommend the Tesla stock at Purchase. |
47 Analysts have issued a sales forecast Tesla 2025 . The average Tesla sales estimate is $107b . This is 9.42% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $128b 31.09% , the lowest is $87.2b 10.75% .
This results in the following potential growth metrics:
2024 | $97.7b | 0.95% |
---|---|---|
2025 | $107b | 9.42% |
2026 | $129b | 21.01% |
2027 | $157b | 21.30% |
2028 | $198b | 26.03% |
2029 | $251b | 26.87% |
34 Analysts have issued an Tesla EBITDA forecast 2025. The average Tesla EBITDA estimate is $16.3b . This is 24.04% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $23.5b 78.92% , the lowest is $10.6b 19.35% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $13.1b | 3.17% |
---|---|---|
2025 | $16.3b | 24.04% |
2026 | $21.0b | 28.85% |
2027 | $27.6b | 31.52% |
2028 | $35.1b | 27.09% |
2029 | $39.6b | 13.00% |
2024 | 13.44% | 4.08% |
---|---|---|
2025 | 15.23% | 13.33% |
2026 | 16.22% | 6.50% |
2027 | 17.59% | 8.45% |
2028 | 17.74% | 0.85% |
2029 | 15.80% | 10.94% |
27 Tesla Analysts have issued a net profit forecast 2025. The average Tesla net profit estimate is $7.1b . This is 8.31% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $11.6b 77.45% , the lowest is $3.2b 51.45% .
This results in the following potential growth metrics and future Net Margins:
2024 | $6.6b | 52.56% |
---|---|---|
2025 | $7.1b | 8.31% |
2026 | $10.3b | 45.16% |
2027 | $12.7b | 22.70% |
2028 | $22.6b | 78.68% |
2029 | $28.5b | 25.92% |
2024 | 6.72% | 53.00% |
---|---|---|
2025 | 6.65% | 0.98% |
2026 | 7.97% | 19.85% |
2027 | 8.07% | 1.25% |
2028 | 11.44% | 41.76% |
2029 | 11.35% | 0.79% |
27 Analysts have issued a Tesla forecast for earnings per share. The average Tesla EPS is $2.21 . This is 8.33% higher than earnings per share in the financial year 2024. The highest EPS forecast is $3.62 77.45% , the lowest is $0.99 51.47% .
This results in the following potential growth metrics and future valuations:
2024 | $2.04 | 52.56% |
---|---|---|
2025 | $2.21 | 8.33% |
2026 | $3.21 | 45.25% |
2027 | $3.94 | 22.74% |
2028 | $7.03 | 78.43% |
2029 | $8.86 | 26.03% |
Current | 118.51 | 198.14% |
---|---|---|
2025 | 109.32 | 7.75% |
2026 | 75.31 | 31.11% |
2027 | 61.38 | 18.50% |
2028 | 34.35 | 44.04% |
2029 | 27.28 | 20.58% |
Based on analysts' sales estimates for 2025, the Tesla stock is valued at an EV/Sales of 7.06 and an P/S ratio of 7.27 .
This results in the following potential growth metrics and future valuations:
Current | 7.72 | 42.17% |
---|---|---|
2025 | 7.06 | 8.60% |
2026 | 5.83 | 17.36% |
2027 | 4.81 | 17.56% |
2028 | 3.81 | 20.65% |
2029 | 3.01 | 21.18% |
Current | 7.95 | 41.28% |
---|---|---|
2025 | 7.27 | 8.61% |
2026 | 6.01 | 17.36% |
2027 | 4.95 | 17.56% |
2028 | 3.93 | 20.65% |
2029 | 3.10 | 21.18% |
Analyst | Rating | Action | Date |
---|---|---|---|
Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Apr 16 2025 |
UBS |
Sell
➜
Sell
|
Unchanged | Apr 10 2025 |
Mizuho |
Outperform
➜
Outperform
|
Unchanged | Apr 10 2025 |
Benchmark |
Buy
➜
Buy
|
Unchanged | Apr 09 2025 |
Wedbush |
Outperform
➜
Outperform
|
Unchanged | Apr 07 2025 |
Goldman Sachs |
Neutral
➜
Neutral
|
Unchanged | Apr 03 2025 |
Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Apr 03 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Apr 16 2025 |
Unchanged
UBS:
Sell
➜
Sell
|
Apr 10 2025 |
Unchanged
Mizuho:
Outperform
➜
Outperform
|
Apr 10 2025 |
Unchanged
Benchmark:
Buy
➜
Buy
|
Apr 09 2025 |
Unchanged
Wedbush:
Outperform
➜
Outperform
|
Apr 07 2025 |
Unchanged
Goldman Sachs:
Neutral
➜
Neutral
|
Apr 03 2025 |
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Apr 03 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.